Navigation Links
TGen-led study finds likely origin of lung fungus invading Pacific Northwest
Date:7/15/2014

FLAGSTAFF, Ariz. - Cryptococcus gattii, a virulent fungus that has invaded the Pacific Northwest is highly adaptive and warrants global "public health vigilance," according to a study by an international team led by the Translational Genomics Research Institute (TGen).

C. gattii, which likely originated in Brazil, is responsible for dozens of deaths in recent years since it was first found in 1999 on Vancouver Island, British Columbia, Canada, well outside its usual tropical habitats.

"We identified several genes that may make the outbreak strains more capable of surviving colder environments and that make it more harmful in the lungs," said David Engelthaler, Director of Programs and Operations for TGen's Pathogen Genomics Division (TGen North) and lead author of the study published today in the scientific journal mBio.

This study should form the basis of additional investigations about how and why C. gattii disperses and emerges. It identified several new genomic targets for diagnostic tests, and possible new targets for therapeutic drugs and preventative vaccines.

"By closely analyzing the genomes of dozens of outbreak strains, as well as globally diverse strains, we were able to closely compare and determine the genomic differences that may cause their clinical and ecological changes," said Dr. Paul Keim, one of the study's senior authors. Dr. Keim also is Director of TGen North, and Director of the Microbial Genetics and Genomics Center at Northern Arizona University (NAU).

TGen, working with the U.S. Centers for Disease Control and Prevention and others, conducted one of the largest global fungal genome analyses of a specific species to understand its emergence in new environments. The collaborative team included 24 researchers from 13 institutions in seven nations who sequenced 115 genomes of C. gattii collected from 15 countries.

"By thinking globally, we were able to better understand what was happening locally," Engelthaler said.

C. gattii was typically a tropical fungus before it was discovered in the temperate environs of Vancouver Island. It soon evolved into a new, more virulent, pulmonary disease that quickly spread to mainland Canada and south into the state of Washington. That was followed by an outbreak in Oregon of another new strain of C. gattii, which also displayed increased lethality and similarly spread throughout the Pacific Northwest.

C. gattii previously was associated with neurological disease in strains found elsewhere in the world. But the strains discovered in the Pacific Northwest not only establish a new environmental niche, but also display increased virulence and produce severe lung infections.

"We provide evidence that the Pacific Northwest strains originated from South America, and identified numerous genes potentially related to habitat adaptation, virulence expression and to clinical presentation," said Dr. Wieland Meyer, the study's other senior author.

"Further elucidation and characterization of these genetic features may lead to improved diagnostics and therapies for infections caused by this continually evolving fungus," said Dr. Meyer, who is affiliated with: Sydney Medical School-Westmead Hospital; the University of Sydney; and the Westmead Millennium Institute for Medical Research.

This study concludes that: "Public health vigilance is warranted for emergence in regions where C. gattii is not thought to be endemic."

New tests developed for this study by TGen are making it easier to detect this and other fungi, and could lead to better monitoring and treatments. The same tools used in this study also were used to investigate the cause of a fungal meningitis outbreak associated with steroid back injections, and the recent outbreak of Valley Fever in the state of Washington.


'/>"/>
Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute
Source:Eurekalert

Related biology news :

1. TGen-led study discovers dramatic changes in bacteria following male circumcision
2. TGen-led research shows ability to do next-generation sequencing for patients with advanced cancers
3. TGen-led study discovers genetic cause of rare type of ovarian cancer
4. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
5. Law that regulates shark fishery is too liberal: UBC study
6. New study will help protect vulnerable birds from impacts of climate change
7. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
8. BYU study: Using a gun in bear encounters doesnt make you safer
9. 15-year study: When it comes to creating wetlands, Mother Nature is in charge
10. Pycnogenol (French maritime pine bark extract) shown to improve menopause symptoms in new study
11. Crystal structure of archael chromatin clarified in new study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... Research and Markets has announced the addition of the ... their offering. ... The global bioinformatics market ... 6.21 Billion in 2016, growing at a CAGR of 21.1% during ... is driven by the growing demand for nucleic acid and protein ...
(Date:11/14/2016)... Nov. 14, 2016  Based on its ... Frost & Sullivan recognizes FST Biometrics with ... for Visionary Innovation Leadership. FST Biometrics emerged ... identification market by pioneering In Motion Identification ... instant, seamless, and non-invasive verification. This patented ...
(Date:6/22/2016)... , June 22, 2016  The American College of Medical ... Show Executive Magazine as one of the fastest-growing trade ... 25-27 at the Bellagio in Las Vegas ... highest percentage of growth in each of the following categories: ... companies and number of attendees. The 2015 ACMG Annual Meeting ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... DENVER, COLORADO (PRWEB) , ... December 05, 2016 ... ... podcast series hosted by one of the nation’s premier cannabis technology and application ... the founder and CEO of Cultivate Colorado. Over the past 30 years, Chip ...
(Date:12/5/2016)... , Dec. 5, 2016  Renova™ Therapeutics, a ... heart failure and other chronic diseases, announced that ... company as Chief Financial Officer (CFO), effective today. ... 20 years of experience in financial management for ... and software companies. Most recently, Ms. Bovenizer was ...
(Date:12/5/2016)... LAKE, N.J. , Dec. 5, 2016 /PRNewswire/ ... Phase 3 open-label two-year study of rufinamide, which ... the American Epilepsy Society (AES) held from December ... Analysis of final two-year safety, tolerability and cognitive ... with rufinamide experienced similar safety and tolerability profiles, ...
(Date:12/4/2016)... ... December 02, 2016 , ... A proposed five-year ... in federally funded research and development is welcome news for the photonics community, ... . , As part of the National Defense Authorization Act (NDAA) compromise agreement ...
Breaking Biology Technology: